Elisa Cappuzzello

2PUBLICATIONS
4CO-AUTHORS
Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 17, 2021
Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells.

Anna Dalla Pietà, Elisa Cappuzzello, Pierangela Palmerini

|Jun 10, 2017
A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action.

Elena Campaner, Alessandra Rustighi, Alessandro Zannini

Pageof 1